Liaoning Cheng Da Co., Ltd. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Liaoning Cheng Da Co., Ltd. with three other
companies in this sector in China:
HPGC Renmintongtai Pharmaceutical Corp
sales of 9.01 billion Chinese Renmimbi [US$1.36 billion]
of which 99%
was Pharmaceutical Commerce),
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd
(6.25 billion Chinese Renmimbi [US$943.44 million]
of which 95%
was Retail Sale), and
Laobaixing Pharmacy Chain Joint Stock Co
(6.09 billion Chinese Renmimbi [US$919.88 million]
of which 94%
was Pharmaceutical retail).
During the year ended December of 2016, sales at
Liaoning Cheng Da Co., Ltd. were 8.75 billion Chinese Renmimbi (US$1.32 billion).
decrease of 4.2%
versus 2015, when the company's sales were 9.13 billion Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Liaoning Cheng Da Co., Ltd. had sales
of 9.66 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 57.6% decline
in Energy Research, from 123.11 million Chinese Renmimbi to 52.26 million Chinese Renmimbi.
There were also decreases in sales in
Trade (down 13.6% to 4.58 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Medicines Sales (up 11.5% to 3.07 billion Chinese Renmimbi)
Drugs Manufacturing (up 9.1% to 1.03 billion Chinese Renmimbi)
Headquarter Office (up 69.2% to 65.58 million Chinese Renmimbi)